CFB
INSM icon

Cullen/Frost Bankers’s Insmed INSM Stock Holding History

Cullen/Frost Bankers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.84M Sell
54,740
-838
-2% -$101K 0.06% 212
2026
Q1 		$9.09M Buy
55,578
+55,322
+21,610% +$8.51M 0.1% 171
2025
Q4 		$44.6K Sell
256
-150
-37% -$27.4K ﹤0.01% 820
2025
Q3 		$58.5K Sell
406
-10
-2% -$1.23K ﹤0.01% 729
2025
Q2 		$41.9K Buy
416
+61
+17% +$4.66K ﹤0.01% 784
2025
Q1 		$27.1K Buy
355
+221
+165% +$16.9K ﹤0.01% 811
2024
Q4 		$9.25K Buy
134
+68
+103% +$4.9K ﹤0.01% 893
2024
Q3 		$4.82K Buy
66
+34
+106% +$2.51K ﹤0.01% 1010
2024
Q2 		$2.14K Buy
+32
New +$1.24K ﹤0.01% 1095
2024
Q1 		– Sell
-5,305
Closed -$164K – 1044
2023
Q4 		$164K Hold
5,305
– – ﹤0.01% 507
2023
Q3 		$134K Hold
5,305
– – ﹤0.01% 569
2023
Q2 		$112K Hold
5,305
– – ﹤0.01% 598
2023
Q1 		$90.5K Buy
+5,305
New +$103K ﹤0.01% 628

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cullen/Frost Bankers's INSM Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Insmed (INSM) stake by 1.5% in Q2 2026, selling an estimated $101K and leaving 54,740 shares worth $5.84M. The position accounts for 0.06% of the portfolio, ranked #212.

Cullen/Frost Bankers first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.09M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cullen/Frost Bankers held 54,740 shares of Insmed worth $5.84M as of Q2 2026.
  • Cullen/Frost Bankers sold 838 Insmed shares in Q2 2026, an estimated $101K.
  • Insmed made up 0.06% of Cullen/Frost Bankers's portfolio in Q2 2026, its #212 holding.
  • Cullen/Frost Bankers first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
  • Cullen/Frost Bankers's Insmed position peaked at $9.09M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.